Company BGI Genomics Co., Ltd.

Equities

300676

CNE100003449

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. 23:00:00 25/04/2024 BST 5-day change 1st Jan Change
39.74 CNY +2.11% Intraday chart for BGI Genomics Co., Ltd. +4.36% -17.21%

Business Summary

BGI Genomics Co., Ltd. is a leading provider of genomic and proteomic sequencing services primarily to academic institutions, pharmaceutical companies and healthcare providers. The company also provides genomic solutions for biomarker research and development, screening for some of the trisomies present at birth (trisomy 21, trisomy 18 and trisomy 13) and solutions for neo-antigen identification for immuno-oncology research.

Sales per Business

CNY in Million2022Weight2023Weight Delta
Comprehensive Solutions for Precision Medical Testing
32.4 %
2,504 35.5 % 1,407 32.4 % -43.79%
Reproductive Health Basic Research and Clinical Application
27.1 %
1,116 15.8 % 1,178 27.1 % +5.55%
Multi-omics Big Data Service and Synthetic
16.3 %
705 10.0 % 707 16.3 % +0.33%
Cancer and Chronic Disease Prevention and Control and Translational Medicine
12.1 %
404 5.7 % 525 12.1 % +30.07%
Infection Prevention and Control Basic Research and Clinical Application
11.9 %
2,301 32.7 % 516 11.9 % -77.59%
Other
0.4 %
17 0.2 % 17 0.4 % +1.42%

Sales per region

CNY in Million2022Weight2023Weight Delta
China (Excluding Hong Kong, Macau and Taiwan)
79.5 %
3,622 51.4 % 3,459 79.5 % -4.50%
Asia (Including Hong Kong, Macau and Taiwan) and Oceania
12.8 %
2,791 39.6 % 558 12.8 % -80.02%
Europe and Africa
5.0 %
389 5.5 % 217 5.0 % -44.20%
Americas
2.7 %
245 3.5 % 116 2.7 % -52.53%

Managers

Managers TitleAgeSince
Chief Executive Officer - 15/06/21
Founder 70 -
Director of Finance/CFO 46 15/06/21
Chief Operating Officer 47 18/06/18
Director/Board Member 45 -
Investor Relations Contact - -
Corporate Secretary 40 21/06/15

Members of the board

Members of the board TitleAgeSince
Founder 70 -
Director/Board Member - 28/03/16
Director/Board Member 45 -
- -
Director/Board Member 40 21/06/15
Chief Operating Officer 47 18/06/18
Director/Board Member 48 12/08/21
Chairman 71 15/06/21
Director/Board Member 73 15/06/21
Chief Executive Officer - 15/06/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 417,914,466 215,943,776 ( 51.67 %) 4,000,141 ( 0.9572 %) 51.67 %

Shareholders

NameEquities%Valuation
153,344,167 37.32 % 868 M ¥
Jun Wang
8.389 %
34,470,455 8.389 % 195 M ¥
Wanjia Asset Management Co., Ltd.
4.398 %
18,074,078 4.398 % 102 M ¥
Hwabao WP Fund Management Co., Ltd.
1.580 %
6,493,174 1.580 % 37 M ¥
Nanji E Commerce Co. Ltd. ESOP 2
0.9734 %
4,000,141 0.9734 % 23 M ¥
E Fund Management Co., Ltd.
0.7875 %
3,235,966 0.7875 % 18 M ¥
2,820,936 0.6865 % 16 M ¥
Guotai Asset Management Co., Ltd.
0.5630 %
2,313,567 0.5630 % 13 M ¥
China Southern Asset Management Co., Ltd.
0.4736 %
1,946,320 0.4736 % 11 M ¥
GF Fund Management Co., Ltd.
0.4691 %
1,927,537 0.4691 % 11 M ¥
NameEquities%Valuation
1,903,350 63.66 % 11 M ¥

Holdings

NameEquities%Valuation
224,400,000 37.40% 20,786,172 $
1,065,173 1.28% 4,086,813 $

Company contact information

BGI Genomics Co., Ltd.

7/F, North Building, Xinhuadu Bldg 162 Wusi Road

350003, Fuzhou

+

http://www.genomics.cn
address BGI Genomics Co., Ltd.(300676)
  1. Stock Market
  2. Equities
  3. 300676 Stock
  4. Company BGI Genomics Co., Ltd.